Maintenance Immunotherapy May Extend Survival in Stage 4 Cancers

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2012-032
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Aberrant DNMT3B7 Expression Correlates to Tissue Type, Stage, and Survival Across Cancers

PLoS ONE
Multidisciplinary
2018English

Anti–CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers—Response

Clinical Cancer Research
Cancer ResearchOncology
2019English

CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers

Frontiers in Immunology
AllergyImmunology
2020English

MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers

Canadian Journal of Gastroenterology and Hepatology
MedicineHepatologyGastroenterology
2018English

Antisense Oligonucleotides Extend Survival and Reverse Decrement in Muscle Response in ALS Models

Journal of Clinical Investigation
Medicine
2018English

Survival Correlation of Immune Response in Human Cancers

Oncotarget
Oncology
2019English

Toward Cell Transfer Immunotherapy Against Patient-Specific Mutations in Gastrointestinal Cancers

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

A1C and Survival in Maintenance Hemodialysis Patients

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2007English

How Content Analysis May Complement and Extend the Insights of Discourse Analysis

International Journal of Qualitative Methods, The
Education
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy